- Home
- KRON vs BAFN Comparison
KRON vs BAFN Comparison
Compare KRON & BAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRON
- BAFN
- Stock Information
- Founded
- KRON 2017
- BAFN 1999
- Country
- KRON United States
- BAFN United States
- Employees
- KRON N/A
- BAFN N/A
- Industry
- KRON Medicinal Chemicals and Botanical Products
- BAFN Savings Institutions
- Sector
- KRON Health Care
- BAFN Finance
- Exchange
- KRON Nasdaq
- BAFN Nasdaq
- Market Cap
- KRON 54.4M
- BAFN 61.9M
- IPO Year
- KRON 2020
- BAFN N/A
- Fundamental
- Price
- KRON $0.72
- BAFN $15.79
- Analyst Decision
- KRON Buy
- BAFN
- Analyst Count
- KRON 3
- BAFN 0
- Target Price
- KRON $1.63
- BAFN N/A
- AVG Volume (30 Days)
- KRON 790.8K
- BAFN 10.0K
- Earning Date
- KRON 05-20-2025
- BAFN 04-24-2025
- Dividend Yield
- KRON N/A
- BAFN 2.04%
- EPS Growth
- KRON N/A
- BAFN 113.18
- EPS
- KRON N/A
- BAFN 2.34
- Revenue
- KRON $9,848,000.00
- BAFN $80,167,000.00
- Revenue This Year
- KRON N/A
- BAFN N/A
- Revenue Next Year
- KRON N/A
- BAFN N/A
- P/E Ratio
- KRON N/A
- BAFN $6.75
- Revenue Growth
- KRON 56.62
- BAFN 2.60
- 52 Week Low
- KRON $0.67
- BAFN $10.40
- 52 Week High
- KRON $1.60
- BAFN $19.75
- Technical
- Relative Strength Index (RSI)
- KRON 35.81
- BAFN 51.59
- Support Level
- KRON $0.67
- BAFN $15.42
- Resistance Level
- KRON $0.76
- BAFN $17.45
- Average True Range (ATR)
- KRON 0.05
- BAFN 0.86
- MACD
- KRON -0.01
- BAFN 0.22
- Stochastic Oscillator
- KRON 19.69
- BAFN 53.89
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.
About BAFN BayFirst Financial Corp.
BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.